Sage Journals: Discover world-class research

Abstract

In situ zymography is a very important technique that shows the proteolytic activity in sections and allows researchers to observe the specific sites of proteolysis in tissues or cells. It is normally performed in non-fixed frozen sections and is not routinely performed in calcified tissues. In this study, we describe a technique that maintains proteolytic activity in fixed and decalcified sections obtained after routine paraffin sectioning in conventional microtome and cryostat sections. We used adult rat hemimandibles, which presented bone, enamel, and dentine matrices; the substrate used was dye-quenched-gelatin. Gelatinolytic activity was colocalized with MMP-2 using fluorescent antibodies. Specific proteolytic activity was observed in all sections, compatible with metalloproteinase activity, particularly in dentine and bone. Furthermore, matrix metalloproteinase-2 was colocalized to the sites of green fluorescence in dentine. In conclusion, the technique presented here will allow in situ zymography reactions in fixed, decalcified, and paraffin-embedded tissues, and we showed that paraformaldehyde-lysine-periodate–fixed cryostat sections are suitable for colocalization of gelatinolytic activity and protein labeling with antibodies. (J Histochem Cytochem 57:615–622, 2009)

Keywords

craniofacial tissues in situ zymography dye-quenched-gelatin proteolytic activity fluorescence microscopy immunolabeling matrix metalloproteinase-2 dentine bone

P roteases are enzymes that cleave peptide bonds (Yan and Blomme 2003; Frederiks and Mook 2004), and metalloproteinases and serine proteases are the largest classes of proteases (Lòpez-Otín and Overall 2002).

Protease activity is essential for many physiological and pathological processes, such as embryonic development, organ and tissue morphogenesis, tissue remodeling, wound healing, inflammation, and tumor progression (Crawford and Matrisian 1994–1995; Ray and Stetler-Stevenson 1994; Abiko et al. 1999; Koyama et al. 2000; Waas et al. 2002; Yan and Blomme 2003). The ability to see the activity of proteases in tissues is very important to determine their role.

There are many techniques used to observe and quantify proteases. IHC localizes the presence of specific proteases in tissues, but zymogens cannot be normally differentiated from active proteases by this technique (Frederiks and Mook 2004). ELISAs are also widely used to quantify proteases, especially in fluids, with the disadvantages of not discriminating between active and inactive proteases and no possibility of determining the localization of the enzyme in the tissue. Zymography and Western blotting are assays used to analyze enzyme activity and the amount of protein, respectively, but do not allow the localization of proteases in tissues (Frederiks and Mook 2004). In situ zymography was developed to observe the presence of activated protease in tissues (Galis et al. 1994), with the possibility to colocalize proteolytic activity with specific proteases using antibodies directed to those proteases.

Initially, in situ zymography was performed using an autoradiographic emulsion containing gelatin (Galis et al. 1994, 1995). The gelatinolytic activity resulted in decreased amounts of silver in specific sites that generated dark spots after radiographic development. Fluorescein-coupled gelatin was introduced as an advance in the localization of gelatinolytic activity in tissues (Galis et al. 1995). However, the precise localization of the proteolytic activity in tissues was only improved with the introduction of dye-quenched (DQ)-gelatin, which is a gelatin substrate heavily labeled with FITC molecules, so that fluorescence is quenched unless proteolysis occurs (Oh et al. 1999; Goodall et al. 2001; Lindsey et al. 2001; Pirilä et al. 2001; Teesalu et al. 2001; Wang and Lakatta 2002; Zhang and Salamonsen 2002; Mook et al. 2003; Lee et al. 2004; Sakuraba et al. 2006). Using DQ-substrates, proteolytic activity is observed as fluorescence in a conventional fluorescence microscope. Other quenched fluorogenic substrates developed and commercially available are DQ-casein, DQ-collagen type I, DQ-collagen type IV, and DQ-elastin (Frederiks and Mook 2004).

Figure 1

Longitudinal sections of the odontogenic zone from a rat lower incisor showing secretory stage ameloblasts. (A) Sections fixed with 4% paraformaldehyde (PFA). (B) Sections fixed with paraformaldehyde-lysine-periodate (PLP). Am, ameloblasts; De, dentine; E, enamel matrix; P, dental pulp.

Figure 2

Gelatinolytic activity in forming rat incisor is shown as green fluorescence in sections fixed with PLP. (A) Section without dye-quenched (DQ)-gelatin (1 hr at room temperature): a faint autofluorescence signal is observed mainly in cells. (B) Section treated with DQ-gelatin (1 hr at room temperature): gelatinolytic activity is shown in dentine (De) and bone (Bo). (C) Section treated with DQ-gelatin (24 hr at 37C): increased gelatinolytic activity is seen in dentine (De) and bone (Bo). (D) Section treated with DQ-gelatin with phenanthroline (Phe; 1 hr at room temperature): decreased gelatinolytic activity after incubation with metalloproteinase inhibitor. (E) Section treated with DQ-gelatin with PMSF (1 hr at room temperature): decreased gelatinolytic activity after incubation with serine protease inhibitor. (F) Section treated with DQ-gelatin with Phe and PMSF (1 hr at room temperature): decreased gelatinolytic activity in section incubated with both proteinases inhibitors. P, dental pulp.

Proteases are widely distributed in craniofacial tissues (Abiko et al. 1999) such as oral mucosa (Tsai et al. 2003; Patel et al. 2005; Rajendran et al. 2006), gingiva (Ejeil et al. 2003; Smith et al. 2004; Kumar et al. 2006; Naveau et al. 2007), salivary glands (Kato et al. 1995; Broverman et al. 1998; Nagel et al. 2004), tooth buds (Abiko et al. 1999), dentine (van Strijp et al. 2003; Mazzoni et al. 2007), and forming enamel (Gerlach et al. 2000a, b; Goldberg et al. 2003; Bourd-Boittin et al. 2004). The presence of proteases in craniofacial tissues has been characterized by most authors by IHC (Saruta et al. 2005; Fukumoto et al. 2006; Takamori et al. 2008). Zymography was also used in a variety of studies (Iamaroon et al. 1996; Abiko et al. 1999; Gerlach et al. 2000a, b; Goldberg et al. 2003; Bourd-Boittin et al. 2004; Sakuraba et al. 2006). However, to date, only two studies showed the proteolytic activity in calcified craniofacial tissues in situ (Sakuraba et al. 2006; Sakakura et al. 2007), and many important aspects of proteolysis are not known yet in those tissues.

The major challenge to perform in situ zymography in craniofacial tissues is to prepare thin sections of mineralized tissues without losing proteolytic activity, because those sections are routinely prepared using formaldehyde-based fixatives, followed by decalcification and inclusion in paraffin. Most studies using in situ zymography were done in soft tissues, in which proteolytic activity was observed in non-fixed tissues from which sections were directly cut in a cryostat. In this study, we describe the feasibility of performing in situ zymography in adult craniofacial tissues using the technique described by Rocha et al. (2006) that enables the localization of alkaline phosphatase activity in bone based on the original paraformaldehyde-lysine-periodate (PLP) fixation (McLean and Nakane 1974) or in the 4% paraformaldehyde fixation and EDTA-glycerol decalcification procedure (Mori et al. 1988). The techniques described in this study maintain proteolytic activity in sections prepared and handled routinely in histology laboratories. This assay was developed using adult rat hemimandibles sections, and the proteolytic activity was shown using DQ-gelatin. Gelatinolytic activity was colocalized with MMP-2 using fluorescent antibodies.

Materials and Methods

This study was approved by the Animal Ethics Committee (protocol number 01.1364.53.4). Six 3-month-old Wistar rats were used in this protocol. The animals received water and food ad libitum. After the animals were killed, hemimandibles were removed.

Tissue Preparation

The hemimandibles were immersed in PLP fixative (2% paraformaldehyde, 0.075 M lysine, and 0.01 M sodium periodate, pH 7.4) or in 4% paraformaldehyde (PFA), pH 7.4, at 4C for 48 hr. Thereafter, hemimandibles were washed with PBS containing increasing volumes of glycerol (5%, 10%, and 15%) and decalcified with EDTA-glycerol, pH 7.3 (1.25 g EDTA, 1.25 g NaOH, and 15 ml glycerol in 100 ml of distilled water) at 4C for 1 month. The material was washed in the following solutions for 12 hr each: (a) 15% sucrose and 15% glycerol, (b) 20% sucrose and 10% glycerol, (c) 20% sucrose and 5% glycerol, (d) 20% sucrose, (e) 10% sucrose, (f) 5% sucrose, and (g) 100% PBS.

The odontogenic area of each hemimandible was selected, cut longitudinally, and included in a paraffin of lower fusion point (54C) or frozen in O.C.T. compound by liquid nitrogen. Five-μm longitudinal sections were cut in a microtome (model RM2165; Leica, Nussloch, Germany) or in a cryostat (model CM1510; Leica) and laid on silanized microscope slides. Some sections were stained with hematoxylin and eosin (HE). In situ zymography reactions were done in deparaffined non-stained sections within a month of sectioning.

In Situ Zymography Using DQ-gelatin

The mixture of DQ-gelatin (DQ-gelatin, E12055; Molecular Probes, Eugene, OR) was prepared as follows: 1 mg/ml DQ-gelatin dissolved 1:10 in 50 mM TrisCaCl₂. Forty μl of this mixture was applied on top of the sections, which were incubated at 25C for 1 hr or 37C for 24 hr in a dark humid chamber. The gelatinolytic activity was observed as green fluorescence (absorption maxima, ∼495 nm; fluorescence emission maxima, ∼515 nm) by fluorescence microscopy (Fluorescence Microscope Model Axioskop 50 using camera AxioCam MRC; Carl Zeiss, Oberkochen, Germany).

Negative control sections were incubated in the same way as described above, but without DQ-gelatin. Some sections were incubated either with an metalloproteinase inhibitor, 1,10-phenanthroline (Phe), with a serine protease inhibitor, PMSF (Sigma Chemicals; St. Louis, MO), at 2 mM, or with both inhibitors.

Matrix Metalloproteinase-2 (MMP-2) Immunolabeling

Sections of tissue fixed with PLP and cut in a cryostat were incubated with a mixture of DQ-gelatin. All incubation steps were carried out in a dark humid chamber at room temperature. After 1 hr, the sections were rinsed three times in 0.01 M PBS and then were incubated for 1 hr with anti-MMP-2 monoclonal antibody (mouse anti-MMP-2 antibody MAB3308; Chemicon, Temecula, CA) diluted 1:100 in PBS. After rinsing with PBS, the sections were incubated with rhodamine (Rhodamine Conjugated Anti-Mouse Antibody; Chemicon) diluted 1:200 in PBS for 1 hr and then rinsed three times with PBS. 4′,6-Diamidino-2-phenylindole (DAPI) was applied for 3 min, and specimens were washed with PBS and analyzed by fluorescence microscopy.

Results

The sections fixed with PLP or PFA and stained with HE showed a normal odontogenic zone. Enamel matrix and dentine were observed, and secretory stage ameloblasts were present (Figure 1).

After a 1-hr incubation at 25C, sections fixed with PLP and treated with DQ-gelatin exhibited some fluorescence in the dentine and bone, indicating gelatinolytic activity (Figure 2B) that increased after a 24-hr incubation (Figure 2C). The sections incubated without DQ-gelatin showed only a faint signal, mainly caused by autofluorescence of cells, and the gelatinolytic activity in dentin and bone was not observed (Figure 2A). Sections treated with DQ-gelatin + Phe, DQ-gelatin + PMSF, or both inhibitors showed decreased gelatinolytic activity in dentine and alveolar bone after 1 hr (Figures 2D–2F); the same happened after 24 hr (data not shown).

Figure 3

Gelatinolytic activity in forming rat incisor is shown as green fluorescence in sections fixed with PFA. (A) Section without DQ-gelatin (1 hr at room temperature): faint autofluorescence signal is observed mainly in cells. (B) Section treated with DQ-gelatin (1 hr at room temperature): gelatinolytic activity is shown in dentine (De) and bone (Bo). (C) Section treated with DQ-gelatin 24 hr at 37C: a similar gelatinolytic activity is seen in dentine (De) and bone (Bo). (D) Section treated with DQ-gelatin with phenanthroline (Phe; 1 hr at room temperature): decreased gelatinolytic activity in section incubated with metalloproteinase inhibitor. (E) Section treated with DQ-gelatin with PMSF (1 hr at room temperature): decreased gelatinolytic activity in section incubated with serine protease inhibitor. (F) Section treated with DQ-gelatin with Phe and PMSF (1 hr at room temperature): decreased gelatinolytic activity in section incubated with both proteinase inhibitors. P, dental pulp.

Figure 4

Gelatinolytic activity and metalloproteinase-2 (MMP-2) colocalization in forming rat incisor are shown in sections fixed with PLP. (A) Green fluorescence shows the gelatinolytic activity in dentine (De). (B) Red fluorescence shows the MMP-2 labeling in dentine. (C) Overlapping of A and B and nuclear stain with 4′,6-diamidino-2-phenylindole (DAPI; blue fluorescence). Gelatinolytic activity is observed in dentine and was colocalized with MMP-2 (yellow fluorescence). P, dental pulp. Bar = 100 μm.

A similar pattern was observed in the sections fixed with PFA. In sections incubated without DQ-gelatin, the autofluorescence of cells was observed but no gelatinolytic activity was present (Figure 3A). In sections incubated with DQ-gelatin, the gelatinolytic activity was observed in dentine and alveolar bone after a 1-hr incubation (Figure 3B). The gelatinolytic activity was still observed after a 24-hr incubation, but no increased activity was seen after this time (Figure 3C). The sections treated with inhibitors showed a decrease in gelatinolytic activity (Figures 3D–3F). No gelatinolytic activity was observed in dental enamel.

Specimens fixed with PLP and PFA were also frozen in O.C.T., and cryostat sections were cut and incubated with DQ-gelatin. Results showed the same pattern observed in Figures 2 and 3, with gelatinolytic activity concentrated in dentine and bone and faint fluorescence in sections with no substrate (data not shown). Figure 4 shows a PLP-fixed, cryostat-cut section incubated with DQ-gelatin (Figure 4A) and a monoclonal anti-MMP-2 antibody followed by a secondary antibody labeled with rhodamine (Figure 4B). DAPI was used as a nuclear stain (Figure 4C). Green fluorescence compatible with gelatinolytic activity is observed in dentine and was colocalized with MMP-2, a gelatinolytic proteinase (Figure 4C).

Discussion

In situ zymography using dye-quenched substrates was developed to improve the localization of protease activity in frozen sections of non-fixed tissues. In our study, we showed for the first time the feasibility of doing in situ zymography in fixed and decalcified sections of craniofacial tissues from adult animals. This technique was previously used to show the activity of alkaline phosphatase in bone (Rocha et al. 2006) and is based on the use of PLP fixative, as described by McLean and Nakane (1974), and EDTA-glycerol decalcification (Mori et al. 1988). Decalcification and inclusion of the tissue in low fusion point paraffin allowed sectioning in a conventional microtome, and the results suggest that gelatinolytic activity was preserved in dentine and bone of PLP- and PFA-fixed specimens. Incubation for 1 hr at room temperature was adequate to obtain a strong fluorescent signal.

The green fluorescence observed is compatible with gelatinolytic activity, because it decreased when inhibitors were used (although inhibition was not specific by Phe or PMSF). Furthermore, MMP-2, which is a gelatinolytic proteinase, was colocalized to the sites of green fluorescence in dentine. Some green fluorescent signal (compatible with DQ-gelatin proteolysis) was observed in other parts of the tissue, where no MMP-2 was detected using antibodies. The gelatinases (MMP-2 and MMP-9) have domains that bind gelatin (the fibronectin-like domain) (Briknarová et al. 2001; Xu et al. 2004; Hornebeck et al. 2005), and these domains might bind the substrate where these proteinases are localized in the sections, but this is probably not the reason that explains the strong green fluorescence found in dentine and bone.

The fluorescent signal compatible with gelatinolytic activity and the colocalization with MMP-2 is also in agreement with studies that indicate that MMP-2 is found in dentine (Satoyoshi et al. 2001; Goldberg et al. 2003; Palosaari et al. 2003; van Strijp et al. 2003) and bone (Maruya et al. 2003; César Neto et al. 2004; Accorsi-Mendoça et al. 2008). MMP-2 is probably one of the proteinases whose activity might be preserved to some extend even using paraformaldehyde-based fixatives, because this proteinase has been shown to be resistant to harsh conditions; for example, extracted teeth still showed MMP-2 activity after complete acid demineralization of the dentine in the absence of a fixative (Mazzoni et al. 2007).

Although many studies of in situ zymography have been described in soft tissues (Abiko et al. 1999; Oh et al. 1999; Duchossoy et al. 2001; Goodall et al. 2001; Lindsey et al. 2001; Pirilä et al. 2001; Teesalu et al. 2001; Wang and Lakatta 2002; Zhang and Salamonsen 2002; Mook et al. 2003; Lee et al. 2004; Smith et al. 2004), only a few have described the activity of proteinases in calcified tissues. To our knowledge, Sakuraba et al. (2006) were the first to describe in situ zymography in tooth germs of young animals, using quenched fluorogenic substrates in non-fixed frozen sections prepared in a cryostat. However, the technique cannot be universally used, particularly in calcified tissues of adult animals, because those cannot be normally processed in a cryostat. In our view, the technique presented here has an important advantage, because more laboratories familiar with conventional histological processing will probably be able to look for enzyme activity in bones and teeth.

Another important aspect is that in situ zymography allows colocalization of the proteolytic activity with proteinases using specific antibodies. With the recent increase in the number of quenched fluorogenic substrates available and increasing number of fluorophores available to label secondary antibodies, probably many proteases can be localized to the site of proteolytic activity, and this activity can certainly be monitored over time and checked using specific inhibitors, which expands the arsenal of tools a researcher has to look for the role of one or many proteinases in calcified tissues.

Colocalization of proteolysis with antibody labeling is a reality in soft non-fixed tissues (Evans and Itoh 2007). We showed here that PLP-fixed cryostat sections are suitable for colocalization of gelatinolytic activity and protein labeling with antibodies recommended for IHC.

The fixation of calcified tissues described here may also be useful to prepare samples for embedding in resin and sectioning in hard tissues saws, without losing proteolytic activity, but detailed protocols need to be tested. This is the procedure to avoid altering the mineral content of mineralized tissues. Particularly, new aspects of mineralization of enamel in the maturation stage and the role of proteinases in mineralization will probably be possible in this way.

In conclusion, the technique described here will allow doing in situ zymography in fixed, decalcified, and paraffin-embedded tissues. The use of this technique coupled with the use of specific inhibitors and antibodies will contribute to the understanding of the specific roles played by proteinases in calcified tissues.

Footnotes

Acknowledgements

We gratefully acknowledge the support of Fundação de Pesquisa do Estado de Säo Paulo and Cobnselho Nacional de Pesquisa.

We thank Maria Elena Riul and Mônica Azevedo de Abreu, Department of Pathology, Medicine School of Ribeiräo Preto, for excellent technical assistance in preparation of the specimens.

References

Abiko

Kutsuzawa

Kowashi

Kaku

Tachikawa

(1999) In situ detection of gelatinolytic activity in developing craniofacial tissues. Anat Embryol (Berl) 200:283–287

Accorsi-Mendonça

Paiva

Zambuzzi

Cestari

Lara

Sogayar

Taga

. (2008) Expression of matrix metalloproteinases-2 and −9 and RECK during alveolar bone regeneration in rat. J Mol Histol 39:201–208

Bourd-Boittin

Septier

Hall

Goldberg

Menashi

(2004) Immunolocalization of enamelysin (matrix metalloproteinase-20) in the forming rat incisor. J Histochem Cytochem 52:437–445

Briknarová

Gehrmann

Bányai

Tordai

Patthy

Llinás

(2001) Gelatin-binding region of human matrix metalloproteinase-2: solution structure, dynamics, and function of the COL-23 two-domain construct. J Biol Chem 276:27613–27621

Broverman

Nguyen

da Silveira

Brinkley

Macauley

Zeng

Yamamoto

. (1998) Changes in the expression of extracellular matrix (ECM) and matrix metalloproteinases (MMP) of proliferating rat parotid acinar cells. J Dent Res 77:1504–1514

César Neto

de Souza

Barbieri

Moreno

Jr Sallum

Nociti

Jr (2004) Matrix metalloproteinase-2 may be involved with increased bone loss associated with experimental periodontitis and smoking: a study in rats. J Periodontol 75:995–1000

Crawford

Matrisian

(1994–1995) Tumor and stromal expression of matrix metalloproteinases and their role in tumor progression. Invasion Metastasis 14:234–245

Duchossoy

Arnaud

Feldblum

(2001) Matrix metalloproteinases: potential therapeutic target in spinal cord injury. Clin Chem Lab Med 39:362–367

Ejeil

Igondjo-Tchen

Ghomrasseni

Pellat

Godeau

Gogly

(2003) Expression of matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs) in healthy and diseased human gingiva. J Periodontol 74:188–195

10.

Evans

Itoh

(2007) Analyses of MT1-MMP activity in cells. Methods Mol Med 135:239–249

11.

Frederiks

Mook

(2004) Metabolic mapping of proteinase activity with emphasis on in situ zymography of gelatinases: review and protocols. J Histochem Cytochem 52:711–722

12.

Fukumoto

Miner

Ida

Fukumoto

Yuasa

Miyazaki

Hoffman

. (2006) Laminin alpha5 is required for dental epithelium growth and polarity and the development of tooth bud and shape. J Biol Chem 281:5008–5016

13.

Galis

Sukhova

Lark

Libby

(1994) Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 94:2493–2503

14.

Galis

Sukhova

Libby

(1995) Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB J 9:974–980

15.

Gerlach

de Souza

Cury

Line

(2000a) Effect of lead, cadmium and zinc on the activity of enamel matrix proteinases in vitro. Eur J Oral Sci 108:327–334

16.

Gerlach

de Souza

Cury

Line

(2000b) Fluoride effect on the activity of enamel matrix proteinases in vitro. Eur J Oral Sci 108:48–53

17.

Goldberg

Septier

Bourd

Hall

George

Goldberg

Menashi

(2003) Immunohistochemical localization of MMP-2, MMP-9, TIMP-1, and TIMP-2 in the forming rat incisor. Connect Tissue Res 44:143–153

18.

Goodall

Crowther

Hemingway

Bell

Thompson

(2001) Ubiquitous elevation of matrix metalloproteinase-2 expression in the vasculature of patients with abdominal aneurysms. Circulation 104:304–309

19.

Hornebeck

Bellon

Emonard

(2005) Fibronectin type II (FnII)-like modules regulate gelatinase A activity. Pathol Biol (Paris) 53:405–410

20.

Iamaroon

Tait

Diewert

(1996) Cell proliferation and expression of EGF, TGF-alpha, and EGF receptor in the developing primary palate. J Dent Res 75:1534–1539

21.

Kato

Ozono

Koshika

(1995) Evidence of gelatinase secretion by the submandibular gland in prepubescent rats. Connect Tissue Res 31:219–226

22.

Koyama

Iwata

Kuwabara

Iwase

Kobayashi

Fujii

(2000) Gelatinolytic activity of matrix metalloproteinase-2 and −9 in oesophageal carcinoma; a study using in situ zymography. Eur J Cancer 36:2164–2170

23.

Kumar

Vamsi

Sripriya

Sehgal

(2006) Expression of matrix metalloproteinases (MMP-8 and −9) in chronic periodontitis patients with and without diabetes mellitus. J Periodontol 77:1803–1808

24.

Lee

Tsuji

Lee

(2004) Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia. J Neurosci 24:671–678

25.

Lindsey

Wedin

Brown

Keller

Evans

Smolen

Burns

. (2001) Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 103:2181–2187

26.

López-Otín

Overall

(2002) Protease degradomics: a new challenge for proteomics. Nat Rev Mol Cell Biol 3:509–519

27.

Maruya

Sasano

Takahashi

Kagayama

Mayanagi

(2003) Expression of extracellular matrix molecules, MMPs and TIMPs in alveolar bone, cementum and periodontal ligaments during rat tooth eruption. J Electron Microsc (Tokyo) 52:593–604

28.

Mazzoni

Mannello

Tay

Tonti

Papa

Mazzotti

Di Lenarda

. (2007) Zymographic analysis and characterization of MMP-2 and −9 forms in human sound dentin. J Dent Res 86:436–440

29.

McLean

Nakane

(1974) Periodate-lysine-paraformaldehyde fixative. A new fixation for immunoelectron microscopy. Histochem Cytochem 22:1077–1083

30.

Mook

Van Overbeek

Ackema

Van Maldegem

Frederiks

(2003) In situ localization of gelatinolytic activity in the extracellular matrix of metastases of colon cancer in rat liver using quenched fluorogenic DQ-gelatin. J Histochem Cytochem 51:821–829

31.

Mori

Sawai

Techima

Kyogoku

(1988) A new decalcifying technique for immunohistochemical studies of calcified tissue, especially applicable for cell surface marker demonstration. J Histochem Cytochem 36:111–114

32.

Nagel

Laskawi

Wahlers

Hemmerlein

(2004) Expression of matrix metalloproteinases MMP-2, MMP-9 and their tissue inhibitors TIMP-1, −2, and −3 in benign and malignant tumours of the salivary gland. Histopathology 44:222–231

33.

Naveau

Reinald

Fournier

Durand

Lafont

Coulomb

Gogly

(2007) Gingival fibroblasts inhibit MMP-1 and MMP-3 activities in an ex-vivo artery model. Connect Tissue Res 48:300–308

34.

Larsen

Krekoski

Edwards

Donovan

Werb

Yong

(1999) Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes. J Neurosci 19:8464–8475

35.

Palosaari

Pennington

Larmas

Edwards

Tjäderhane

Salo

(2003) Expression profile of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in mature human odontoblasts and pulp tissue. Eur J Oral Sci 111:117–127

36.

Patel

Shah

Rawal

Desai

Shah

Rawal

Patel

(2005) Activation of MMP-2 and MMP-9 in patients with oral squamous cell carcinoma. J Surg Oncol 90:81–88

37.

Pirilä

Maisi

Salo

Koivunen

Sorsa

(2001) In vivo localization of gelatinases (MMP-2 and −9) by in situ zymography with a selective gelatinase inhibitor. Biochem Biophys Res Commun 287:766–774

38.

Rajendran

Rajeesh

Shaikh

Shanthi Pillai

(2006) Expression of matrix metalloproteinases (MMP-1, MMP-2 and MMP-9) and their inhibitors (TIMP-1 and TIMP-2) in oral submucous fibrosis. Indian J Dent Res 17:161–166

39.

Ray

Stetler-Stevenson

(1994) The role of matrix metalloproteases and their inhibitors in tumour invasion, metastasis and angiogenesis. Eur Respir J 7:2062–2072

40.

Rocha

Adam

Leite

Metze

Rossi

(2006) Biomineralization of polyanionic collagen-elastin matrices during cavarial bone repair. J Biomed Mater Res A 79:237–245

41.

Sakakura

Hosokawa

Tsuruga

Irie

Yajima

(2007) In situ localization of gelatinolytic activity during development and resorption of Meckel's cartilage in mice. Eur J Oral Sci 115:212–223

42.

Sakuraba

Hatakeyama

Takahashi

Mayanagi

Sasano

(2006) The MMP activity in developing rat molar roots and incisors demonstrated by in situ zymography. J Mol Histol 37:87–93

43.

Saruta

Tsukinoki

Sasaguri

Ishii

Yasuda

Osamura

Watanabe

. (2005) Expression and localization of chromogranin A gene and protein in human submandibular gland. Cells Tissues Organs 180:237–244

44.

Satoyoshi

Kawata

Koizumi

Inoue

Itohara

Teranaka

Mikuni-Takagaki

(2001) Matrix metalloproteinase-2 in dentin matrix mineralization. J Endod 27:462–466

45.

Smith

Muñoz

Collados

Oyarzún

(2004) In situ detection of matrix metalloproteinase-9 (MMP-9) in gingival epithelium in human periodontal disease. J Periodontal Res 39:87–92

46.

Takamori

Hosokawa

Deng

Bringas

Jr Chai

(2008) Epithelial fibroblast growth factor receptor 1 regulates enamel formation. J Dent Res 87:238–243

47.

Teesalu

Hinkkanen

Vaheri

(2001) Coordinated induction of extracellular proteolysis systems during experimental autoimmune encephalomyelitis in mice. Am J Pathol 159:2227–2237

48.

Tsai

Hsieh

Yang

Chou

Chang

(2003) Matrix metalloproteinase 2 and matrix metalloproteinase 9 expression in human oral squamous cell carcinoma and the effect of protein kinase C inhibitors: preliminary observations. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95:710–716

49.

van Strijp

Jansen

DeGroot

ten Cate

Everts

(2003) Host-derived proteinases and degradation of dentine collagen in situ. Caries Res 37:58–65

50.

Waas

Lomme

DeGroot

Wobbes

Hendriks

(2002) Tissue levels of active matrix metalloproteinase-2 and −9 in colorectal cancer. Br J Cancer 86:1876–1883

51.

Wang

Lakatta

(2002) Altered regulation of matrix metalloproteinase-2 in aortic remodeling during aging. Hypertension 39:865–873

52.

Wang

Lauer-Fields

Fields

Steffensen

(2004) Contributions of the MMP-2 collagen binding domain to gelatin cleavage. Substrate binding via the collagen binding domain is required for hydrolysis of gelatin but not short peptides. Matrix Biol 23:171–181

53.

Yan

Blomme

(2003) In situ zymography: a molecular pathology technique to localize endogenous protease activity in tissue sections. Vet Pathol 40:227–236

54.

Zhang

Salamonsen

(2002) In vivo evidence for active matrix metalloproteinases in human endometrium supports their role in tissue breakdown at menstruation. J Clin Endocrinol Metab 87:2346–2351

In Situ Zymography and Immunolabeling in Fixed and Decalcified Craniofacial Tissues

Abstract

Keywords

Materials and Methods

Tissue Preparation

In Situ Zymography Using DQ-gelatin

Matrix Metalloproteinase-2 (MMP-2) Immunolabeling

Results

Discussion

Footnotes

Acknowledgements

References